View in EDS

Discovery of Adamantane Carboxamides as Ebola Virus Cell Entry and Glycoprotein Inhibitors.

Saved in:
Bibliographic Details
Title: Discovery of Adamantane Carboxamides as Ebola Virus Cell Entry and Glycoprotein Inhibitors.
Authors: Plewe MB; Arisan Therapeutics, 11189 Sorrento Valley Road, Suite 104, San Diego, California 92121, United States., Sokolova NV; Arisan Therapeutics, 11189 Sorrento Valley Road, Suite 104, San Diego, California 92121, United States., Gantla VR; Arisan Therapeutics, 11189 Sorrento Valley Road, Suite 104, San Diego, California 92121, United States., Brown ER; Arisan Therapeutics, 11189 Sorrento Valley Road, Suite 104, San Diego, California 92121, United States., Naik S; Arisan Therapeutics, 11189 Sorrento Valley Road, Suite 104, San Diego, California 92121, United States., Fetsko A; Arisan Therapeutics, 11189 Sorrento Valley Road, Suite 104, San Diego, California 92121, United States., Lorimer DD; Seattle Structural Genomics Center for Infectious Disease (SSGCID), Seattle, Washington 98105, United States.; UCB Pharma, 7869 NE Day Road West, Bainbridge Island, Washington 98110, United States., Dranow DM; Seattle Structural Genomics Center for Infectious Disease (SSGCID), Seattle, Washington 98105, United States.; UCB Pharma, 7869 NE Day Road West, Bainbridge Island, Washington 98110, United States., Smutney H; Seattle Structural Genomics Center for Infectious Disease (SSGCID), Seattle, Washington 98105, United States.; UCB Pharma, 3 Preston Court, Bedford, Massachusetts 01730, United States., Bullen J; Seattle Structural Genomics Center for Infectious Disease (SSGCID), Seattle, Washington 98105, United States.; UCB Pharma, 7869 NE Day Road West, Bainbridge Island, Washington 98110, United States., Sidhu R; Seattle Structural Genomics Center for Infectious Disease (SSGCID), Seattle, Washington 98105, United States.; UCB Pharma, 3 Preston Court, Bedford, Massachusetts 01730, United States., Master A; Seattle Structural Genomics Center for Infectious Disease (SSGCID), Seattle, Washington 98105, United States.; UCB Pharma, 3 Preston Court, Bedford, Massachusetts 01730, United States., Wang J; Seattle Structural Genomics Center for Infectious Disease (SSGCID), Seattle, Washington 98105, United States.; UCB Pharma, 3 Preston Court, Bedford, Massachusetts 01730, United States., Kallel EA; Victrix, 12631 Bendito Drive, San Diego, California 92128, United States., Zhang L; Department of Pathology andCenter for Biodefense and Emerging Infectious Diseases, The University of Texas Medical Branch, Galveston, Texas 77555, United States., Kalveram B; Department of Pathology andCenter for Biodefense and Emerging Infectious Diseases, The University of Texas Medical Branch, Galveston, Texas 77555, United States., Freiberg AN; Department of Pathology andCenter for Biodefense and Emerging Infectious Diseases, The University of Texas Medical Branch, Galveston, Texas 77555, United States.; Department of Pathology andCenter for Biodefense and Emerging Infectious Diseases, The University of Texas Medical Branch, Galveston, Texas 77555, United States., Henkel G; Arisan Therapeutics, 11189 Sorrento Valley Road, Suite 104, San Diego, California 92121, United States., McCormack K; Arisan Therapeutics, 11189 Sorrento Valley Road, Suite 104, San Diego, California 92121, United States.
Source: ACS medicinal chemistry letters [ACS Med Chem Lett] 2020 May 01; Vol. 11 (6), pp. 1160-1167. Date of Electronic Publication: 2020 May 01 (Print Publication: 2020).
Publication Type: Journal Article
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101521073 Publication Model: eCollection Cited Medium: Print ISSN: 1948-5875 (Print) Linking ISSN: 19485875 NLM ISO Abbreviation: ACS Med Chem Lett Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1948-5875
DOI:10.1021/acsmedchemlett.0c00025